Mittendorf, Elizabeth A.
King, Tari A.
Article History
Received: 31 December 2018
First Online: 24 February 2019
DISCLOSURES
: EAM has no relevant disclosures but does report having received compensation for participating in scientific advisory boards for Amgen, Astra-Zeneca, Genentech/Roche, Merck, Peregrine, SELLAS, and Tapimmune. TAK has received honoraria as a speaker and for participating in scientific advisory boards for Genomic Health.